Fox Rothschild's representation of Starton Therapeutics was featured in the Business Wire article, "Starton Therapeutics Inc. And Healthwell Acquisition Corp. I to Combine and Create Publicly Traded Leader in Proprietary Continuous Delivery Technology for Cancer Treatments." View the full article.